The penny stock we picked in October, Adeona Pharmaceuticals, Inc. (AMEX: AEN), developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, has gained 328.81% since our alert. AEN has been given approval at yesterday’s special meeting of stockholders to change its corporate name to Synthetic Biologics, Inc.
AEN shares will start trading under its new name and stock ticker symbol, “SYN“, effective as of market open today, Thursday, February 16, 2012.
AEN Stock Chart From October 26 Alert to February 15:
Synthetic Biologics’ common stock has been assigned a new CUSIP number of 87163U102 in connection with the name change. Outstanding stock certificates are not affected by the name change and will not need to be exchanged.
About Synthetic Biologics, Inc.
Synthetic Biologics is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Synthetic Biologics is developing, or has partnered the development of, product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis (ALS).Share